3 Cash Rich Semiconductor Stocks

Brittney Barrett |

The old adage that cash is king is regularly applied to stocks. More than a trite phrase though, a company’s cash pad can often be an indicator of a stocks safety, ability to initiate new growth and pay dividends. This is especially true when investing in a sector where many of the companies are producing duplicate products, for example semiconductors.  All semiconductors are not created equal, but many investors, without an advanced technology background may have trouble assessing the value of one product to the market over another. In those instances, it’s always best to look at the balance sheet.

Below are three cash rich companies within the sector that are ranked by their cash equivalents. CE can be employed by analysts to assess the cash support in place at companies battling for the same market share.

It’s not surprise that Intel (INTC), the largest producer of semiconductors internationally has the most impressive CE. Intel, which is rumored to be a possible candidate for Apple’s (AAPL) chip manufacturing business, has a CE of $11.98B;

The CE of Analog Devices (ADI) is dramatically beneath that of industry-giant, Intel but still maintains an impressive CE of $3.43B. The company, which engages in design, manufacturing and marketing of signal processing integrated circuits, has a market cap of $12.5 billion with shares up near 9 percent year to date as of Monday.

Altera (ALTR) ranks third with CE of $3.1B. The company, which manufactures and markets high-performance, high-density programmable logic devices, has a P/E ratio of 18.16.





DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Symbol Name Price Change % Volume
SCHW.P.B Charles Schwab Corporation Depositary Shares Repre n/a n/a n/a n/a


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets


Voleo is a free download that allows you to form investment clubs with your friends, family, colleagues, classmates, teammates…basically anyone you know and trust. Invest and manage a stock portfolio…

iPRO Network, LLC

We provide the platform, tools, and resources to empower individuals and professionals to market desirable goods and services to the public, taking the place of traditional methods of commerce.